Lifeward appoints Mark Grant as President and CEO, effective June 2, 2025

Lifeward Ltd.

Mark Grant will become CEO on June 2; Larry Jasinski serves as Co-CEO through June 30, then advisory through 2025.
Grant received inducement option grant of 400,000 shares, vesting over 4 years, at closing price on grant date.
Employment agreement includes $435,000 base salary, up to 70% annual bonus, and severance provisions.
Grant brings 30 years of healthcare leadership, most recently as President of Americas at Medtronic and IMRA Surgical.
Transition is planned; Jasinski will remain available on an as-needed basis through end of 2025.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Mark Grant

President and Chief Executive Officer

LFWD · Lifeward Ltd.

Effective: 2025-06-02
Filed: May 19, 2025, 7:59 PM ET

the Board of Directors (the “Board”) of Lifeward Ltd. (the “Company”) approved the appointment of Mark Grant as the Company’s President and Chief Executive Officer, effective June 2, 2025

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Grant was appointed as President and Chief Executive Officer at Lifeward Ltd..

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

the Board of Directors (the “Board”) of Lifeward Ltd. (the “Company”) approved the appointment of Mark Grant as the Company’s President and Chief Executive Officer, effective June 2, 2025

View on SEC.gov

Lifeward Ltd. filing history →

Source: SEC EDGAR

accession 0001178913-25-001862

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.